logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > Highly Effective Mildronate Dehydrate CAS 86426-17-7

Highly Effective Mildronate Dehydrate CAS 86426-17-7

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 86426-17-7

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:

CAS 86426-17-7 Mildronate Dehydrate

,

Highly Effective Mildronate Dehydrate

Appearance::
White To Off-white Powder
CAS NO::
86426-17-7
Molecular Formula::
C6H18N2O4
Molecular Weight::
182.21800
EINECS NO::
695-494-3
MDL NO::
MFCD13461779
Appearance::
White To Off-white Powder
CAS NO::
86426-17-7
Molecular Formula::
C6H18N2O4
Molecular Weight::
182.21800
EINECS NO::
695-494-3
MDL NO::
MFCD13461779
Highly Effective Mildronate Dehydrate CAS 86426-17-7

Product Description:

Product Name: Mildronate dehydrate CAS NO: 86426-17-7


Synonyms:

3-(2,2,2-Trimethylhydrazinium)propionate dihydrate;

Hydrazinium, 2-(2-carboxyethyl)-1,1,1-trimethyl-, inner salt;

Meldonium;


Chemical & Physical Properties:

Appearance: White to off-white powder

Assay :≥99.00%

Storage Temp.: 2-8℃

Solubility: H2O: >40mg/mL


Safety Information:

Hazard Code: Xi

Risk Statements: R36/37/38

Safety Statement: S26

WGK Germany: 3

Symbol: GHS07

Signal Word: Warning

Hazard Statements: H315-H319-H335

Precautionary Statements: P261-P305 + P351 + P338


At present, the commonly used drugs for the prevention and treatment of myocardial ischemia in clinic mainly include nitrate esters, β-blockers, calcium channel blockers and Chinese herbal medicine. Their mechanism of action is to increase the blood supply to the myocardium. Reduce oxygen consumption; Protect ischemic cardiomyocytes from damage to serosal membrane mitochondria and nuclear membrane; Improve myocardial metabolism, increase the supply of nutrient substrates and penetrate into ischemic areas. In recent years, the role of drugs to improve myocardial metabolism in preventing myocardial ischemia-reperfusion Chemicalbook injury has attracted much attention from many scholars. Myocardial metabilityameliorants are drugs that increase myocardial tolerance to ischemia and/or reperfusion injury by improving myocardial metabolism at the myocyte level. Therefore, it has obvious myocardial protective effect, and has no obvious effect on hemodynamic parameters, cardiac blood supply and cardiac oxygen consumption have no significant changes. These drugs are also known as cellular antiischemia agents because of their distinct differences with other antiischemia agents.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.